2. What is Haemophilia?
• Haemophilia is a bleeding disorder that slows the
blood clotting process. People with this condition
experience prolonged bleeding.
• The major types of this condition are
haemophilia A (factor VIII deficiency) and
haemophilia B (factor IX deficiency
3. History of Haemophilia
• First recognized by the Jews
• It became known as the royal disease
• The word ‘haemophilia’ was first used in
1828
• In 1952 haemophilia B was named after
Stephen Christmas.
6. DEMOGRAPHICS
• Haemophilia occur much more commonly in males.
• Haemophilia A is the most common type of the condition; 1 in
4,000 to 1 in 5,000 males worldwide are born with this
disorder.
• Haemophilia B occurs in approximately 1 in 20,000 newborn
males worldwide.
• By race/ethnicity, the prevalence is 13.2 cases in 100,000
among white males, 11.0 among African-American males, and
11.5 among Hispanic males.
• Haemophilia C occurs primarily among individuals of Jewish
descent
7. BIOCHEMICAL BASIS OF HAEMOPHILIA
Homeostasis- Cessation of bleeding. Coagulation
of bleeding.
Two types of hemostasis:
• Primary hemostasis: A platelet plug is formed
• Secondary hemostasis: Blood clot formation
11. Gene Structure and Expression
•Hemophilia may be caused by a defect
in one of the genes that determine
how the body makes blood clotting
factor VIII or IX.
•The genes are located on the X
chromosome.
13. Biosynthesis and Biochemistry Factor VIII
•Factor VIII or antihemophilic factor
•A nonenzymatic protein
•2351 amino acids
•Circulates in plasma in complex with von Willibrand
Factor(vWF)
•Biosynthesis occurs in the liver and spleen primarily.
•Function -participate in blood coagulation.
•It is a cofactor for factor IXa which converts factor
X to the activated form (Xa).
14. Biosynthesis and Biochemistry Factor IX
• Factor IX (Christmas factor, or hemophilia B factor)
• Produced as a zymogen and circulates in plasma.
• 415 amino acids.
• Is a member of the vitamin K–dependent protein family
• Is cleaved by factor XIa or factor VIIa to produce a two-chain
form where the chains are linked by a disulfide bridge.
• When activated into factor IXa, in the presence of Ca2+,
membrane phospholipids, and a Factor VIII cofactor, it
hydrolyses one arginine-isoleucine bond in factor X to form
factor Xa.
• Function-in blood coagulation it activates factor X to factor Xa.
15. SIGNS and SYMPTOMS of HAEMOPHILIA
1. Excessive Bleeding: bleeding can occur
externally or internally
•External
•Bleeding in the mouth from a cut or bite or
from cutting or losing a tooth
•Nosebleeds for no obvious reason
•Heavy bleeding from a minor cut
•Bleeding from a cut that resumes after
stopping for a short time
16. Internal Bleeding
•Blood in the urine (from bleeding in the
kidneys or bladder)
•Blood in the stool (from bleeding in the
intestines or stomach)
•Large bruises (from bleeding into the
large muscles of the body)
17. Bleeding in the joints:
•Bleeding in the knees, elbows, or other joints is
another common form of internal bleeding
•The bleeding causes tightness in the joint with
no real pain or any visible signs of bleeding.
•The joint then becomes swollen, hot to touch,
and painful to bend. Swelling continues as
bleeding continues.
•Movement in the joint is temporarily lost
18. Bleeding in the brain:
•Long-lasting, painful headaches or neck
pain or stiffness
•Repeated vomiting
•Sleepiness or changes in behaviour
•Sudden weakness or clumsiness of the
arms or legs or problems walking
•Double vision
•Convulsions or seizures
19. DIAGNOSIS
• By family history
• Haemophilia is diagnosed by taking
sample and measuring the level of
factor activity in the blood.
20. TREATMENT OPTIONS
• Treatment with Replacement Therapy
• Desmopressin
• Antifibrinolytic Medicines
• Treatment of a Specific Bleeding Site
T